Robert Ellis

Robert Ellis has extensive experience in quality assurance and regulatory affairs. Robert currently works as the Manager of Quality Systems at BioLab Sciences since October 2022. Prior to that, they were the Quality Assurance Manager at CAPS® (Central Admixture Pharmacy Services) from August 2019 to October 2022. From May 2017 to April 2019, they served as the Director of Quality Assurance/Regulatory Affairs at Summit Pharmaceuticals AZ, where they managed and oversaw various operations including quality systems, FDA and third-party audits, international regulatory product applications, and agency communication.

Before that, Robert held positions as a Senior Quality Assurance Consultant at Oxford Global Resources in 2016 and 2015, where they conducted complex investigations, mentored client investigators, and audited deviation systems for compliance to FDA regulations. In 2014, they worked as a Quality Assurance Consultant at ProPharma Group, executing a retrospective review of Annual Product Reviews for FDA remediation.

Additionally, Robert worked as a Principal Consultant at Parexel International and was a team member for investigation and deviation at a confidential pharmaceutical company in 2012. Robert also served as a Principal Consultant at Parexel International from July 2012 to March 2014, conducting mentoring sessions and developing lesson plans on QC investigations.

Earlier in their career, Robert worked as a Quality Assurance Consultant at Validant from November 2010 to June 2012, performing process deviation investigations and implementing CAPAs. Robert also worked as a Quality Consultant at Hospira from November 2010 to June 2012 and as a Quality Assurance Associate at W.L. Gore & Associates from January 2008 to October 2010, handling product issues, implementing corrective actions, and reviewing product complaints.

From 1986 to 1989, Robert Ellis attended Northern Arizona University. However, no specific degree or field of study was mentioned during this period.